FBTCX
Price
$22.98
Change
+$0.07 (+0.31%)
Updated
Dec 24 closing price
FSPHX
Price
$29.65
Change
+$0.05 (+0.17%)
Updated
Dec 24 closing price
Ad is loading...

FBTCX vs FSPHX

Header iconFBTCX vs FSPHX Comparison
Open Charts FBTCX vs FSPHXBanner chart's image
Fidelity Advisor Biotechnology C
Price$22.98
Change+$0.07 (+0.31%)
VolumeN/A
CapitalizationN/A
Fidelity Select Health Care
Price$29.65
Change+$0.05 (+0.17%)
VolumeN/A
CapitalizationN/A
FBTCX vs FSPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTCX vs. FSPHX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTCX is a StrongBuy and FSPHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 7.51B vs. FBTCX (1.74B). FBTCX (0.00) and FSPHX (0.00) have matching dividends . FBTCX was incepted earlier than FSPHX: FBTCX (24 years) vs FSPHX (43 years). FBTCX is a more actively managed with annual turnover of: 78.00 vs. FSPHX (40.00). FBTCX (0) and FSPHX (0) have matching initial minimum investment requirements. FBTCX annual gain was more profitable for investors over the last year : 10.52 vs. FSPHX (5.00). FSPHX return over 5 years is better than : 3.59 vs. FBTCX (-3.35).
FBTCXFSPHXFBTCX / FSPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years43 years-
Gain YTD6.5582.921225%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.74B7.51B23%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.525.00210%
Returns for 3 years5.00-8.59-58%
Returns for 5 years-3.353.59-93%
Returns for 10 years3.8835.9011%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFNAX81.740.69
+0.85%
American Funds Fundamental Invs 529A
FDTOX34.690.28
+0.81%
Fidelity Advisor Diversified Stock A
IRSEX15.200.05
+0.33%
Delaware Real Estate Securities R6
DMCVX30.490.09
+0.30%
BNY Mellon Opportunistic Midcap Value A
MSMFX13.69N/A
N/A
Morgan Stanley Inst Discovery C